Product NDC: | 60505-2795 |
Proprietary Name: | IBANDRONATE SODIUM |
Non Proprietary Name: | IBANDRONATE SODIUM |
Active Ingredient(s): | 150 mg/1 & nbsp; IBANDRONATE SODIUM |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2795 |
Labeler Name: | Apotex Corp |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078948 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120319 |
Package NDC: | 60505-2795-0 |
Package Description: | 3 BLISTER PACK in 1 PACKAGE (60505-2795-0) > 1 TABLET, FILM COATED in 1 BLISTER PACK |
NDC Code | 60505-2795-0 |
Proprietary Name | IBANDRONATE SODIUM |
Package Description | 3 BLISTER PACK in 1 PACKAGE (60505-2795-0) > 1 TABLET, FILM COATED in 1 BLISTER PACK |
Product NDC | 60505-2795 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | IBANDRONATE SODIUM |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120319 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp |
Substance Name | IBANDRONATE SODIUM |
Strength Number | 150 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |